Alks stock after hours

Insider Summary for Alkermes plc (ALKS) Form 3, Form 4, and Form 5 Insider Trades : Last 3 Mo: Last 12 Mo: Number of Insider Trades : 10: 92: Number of Buys: 5: 48: Number of Sells: 5: 44: Net Activity

What Happened in the Stock Market Today As stocks began the new quarter with a big sell-off, Humana rose on news of talks with Walmart and Alkermes tumbled following a rejected drug application. ALKS, Alkermes Plc - Stock Investment Research, IBD Stock ... Nov 06, 2019 · Get the latest price and volume on Alkermes Plc in IBD stock charts. Our investment research resources are provided to help you make informed investment decisions. ALKS, Alkermes Plc - Stock Investment Research, IBD Stock Charts - Investors.com Alkermes cut to Sell at Goldman - Alkermes plc (NASDAQ ...

Alkermes cut to Sell at Goldman - Alkermes plc (NASDAQ ...

Alkermes cut to Sell at Goldman - Alkermes plc (NASDAQ ... Dec 18, 2018 · It's the third Sell (or equivalent) rating for ALKS in less than a week. Source: Bloomberg Shares were down a bit in after hours action, but are currently flat. Alkermes PLC Research & Ratings (ALKS) | Barron's Feb 07, 2020 · View today's stock price, news and analysis for Alkermes PLC (ALKS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … ALKS Price Target and Analyst Ratings (Alkermes) | MarketBeat Nov 09, 2019 · Their average twelve-month price target is $22.75, suggesting that the stock has a possible upside of 57.66%. The high price target for ALKS is $28.00 and the low price target for ALKS is $17.00. There are currently 1 sell rating, 9 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."

6 days ago Alkermes plc Ordinary Shares (ALKS) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US 

ALKS - Alkermes Plc Stock quote - CNNMoney.com Find real-time ALKS - Alkermes Plc stock quotes, company profile, news and forecasts from CNN Business. Alkermes (NASDAQ:ALKS) Ratings | Benzinga Jan 01, 2010 · Alkermes plc (NASDAQ: ALKS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Alkermes plc (NASDAQ:ALKS), Acorda Therapeutics, Inc ... Nov 08, 2019 · Alkermes stock has had a tough go over the past year, with a negative Adcom verdict on its ALKS 5461 as an adjunctive treatment for major depressive disorder — and the …

Dec 18, 2018 · It's the third Sell (or equivalent) rating for ALKS in less than a week. Source: Bloomberg Shares were down a bit in after hours action, but are currently flat.

Alkermes PLC historical stock charts and prices, analyst ratings, financials, and today’s real-time ALKS stock price. Dow Jones, a News Corp company AFTER HOURS 5:33 PM EDT 03/20/20 NASDAQ:ALKS Alkermes plc - Stock Market Mentor Alkermes PLC is a biotechnology company. It is engaged in developing, manufacturing and commercializing medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious diseases. After-hours buzz: MSFT, ALKS, PYPL and more Oct 20, 2016 · After-hours buzz: MSFT, ALKS, PYPL and more Microsoft saw its stock jump 5 percent after reporting earnings that Shares of Skechers fell more than 14 percent in after-hours trade after the

What Happened in the Stock Market Today As stocks began the new quarter with a big sell-off, Humana rose on news of talks with Walmart and Alkermes tumbled following a rejected drug application.

View Alkermes PLC - (ALKS) Stock Price for pre-market, after-hours and regular trading sessions in a minute-by-minute Volume-Weighted Average Price (VWAP) table. Alkermes Plc Stock Quote: ALKS Stock News, Quotes ... Nov 07, 2019 · ALKS, Alkermes Plc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Alkermes plc (ALKS) Company Profile & Facts - Yahoo Finance See the company profile for Alkermes plc (ALKS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

Alkermes Soars As Antidepressant Finally Delivers At Trials soared more than 45% in after-hours trading, Alkermes stock plunged 44% on Jan. 21 after the drug failed two late-stage trials Insider Summary for Alkermes plc (ALKS) Form 3, Form 4, and Form 5 Insider Trades : Last 3 Mo: Last 12 Mo: Number of Insider Trades : 10: 92: Number of Buys: 5: 48: Number of Sells: 5: 44: Net Activity Alkermes (ALKS) Stock Rips Higher On Phase III Data, Is ... Oct 20, 2016 · Alkermes Plc (NASDAQ: ALKS). Alkermes plc is ripping higher after hours after the company announced positive results from its experimental antidepressant drug, …